Isagro sales down 8% in Q1 2019

Date:05-17-2019

Isagro sales decreased 8.3% to 38.7 Euro million in the first quarter 2019, and its EBITDA dropped by 6.7% to 4.2 million in this quarter.

Perspectives

On a like-for-like basis, in 2019 Isagro expects a substantial consolidation of 2018 revenues from agropharma, with expectations of a significant growth in the mid-term thanks particularly to the new fungicide Fluindapyr. It is thus confirmed the objective of Isagro to achieve a turnover of 200 Euro million in the mid-term, also catching opportunities of external growth, with a better definition of its asset allocation.